Skip to main content
Premium Trial:

Request an Annual Quote

Tripos, Continuing Reorganization, Sells Four UK Buildings

NEW YORK (GenomeWeb News) — Tripos has sold four buildings at its Bude, UK, Discovery Research location to real estate investors and Park Research, a local chemistry company, according to a Securities and Exchange Commission filing last week.
The move, part of Tripos’ plan to sell its chemical research units, enabled the company to recognize around $1.3 million in gross proceeds.
On Nov. 14 Tripos said it was “engaged in advanced discussions” for the sale of the entire Discovery Research division, of which the UK facilities were a part.
The company is currently trying to become a privately held entity that will focus exclusively on developing and marketing its software and informatics business, which was bought by Vector Capital on Nov. 20 for $26.5 million in cash.
As part of Vector, the informatics business will continue to operate under the Tripos name, will remain in St. Louis, and will retain much of the same informatics and software research staff.

Filed under

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.